IL4 and cancer: In particular, the DAC treatment seems to be more effective in inhibiting angiogenesis, cell migration/proliferation and oxidative stress through TGF-beta and IL-4 signaling respectively, while TSA seems more efficient in inducing the repression of cancer immunosurveillance beyond bone resorption and remodeling signaling.